Litigation
More Litigation Articles
Litigation
Reception Will Honor Authors of Critically Acclaimed Commercial Litigation Treatise
On October 26, 2015, Thomson Reuters and the New York County Lawyers Association (NYCLA) will host a reception to honor the 182 principal authors of the new Fourth Edition of their critically acclaimed treatise Commercial Litigation in New York State Courts. The reception, which will be combined...
Read MoreIntellectual Property
Third Circuit Wades Into Intersection of IP and Antitrust: First gloss on FTC v. Actavis focuses on non-monetary branded-generic deals
On June 26, 2015, the Third Circuit became the first circuit court to interpret the United States Supreme Court’s landmark decision, FTC v. Actavis, 133 S. Ct. 2223 (2013), which held that reverse cash or “pay for delay” payments from a patent holder to a generic manufacturer are...
Read MoreFood & Beverage | Healthcare | Medical Devices
Disastrous Results Await New Drug Safety Rule: Generics face flood of suits if preemption defense slips away
Over the past few years, generic drug manufacturers, whose prescriptions account for 86 percent of the market and 29 percent of total U.S. drug sales, have achieved significant legal victories. These include two Supreme Court decisions finding that federal law preempts state law failure-to-warn and...
Read More
